Phase II open-label, global study evaluating dabrafenib in combination with trametinib in pediatric patients with BRAF V600-mutant high-grade glioma (HGG) or low-grade glioma (LGG)

Hargrave, D ; Witt, O ; Cohen, K ; Packer, R ; Lissat, A ; Kordes, U ; Laetsch, T W ; Hoffman, L ; Lassaletta, A ; Gerber, N U ; Gilheeney, S ; Holm, S ; Kramm, C ; Sumerauer, D ; Reitmann, C ; Russo, M W ; Bouffet, E

England

Texto completo disponível

Randomized, double-blind, dose-ranging trial of the oral neurokinin-1 receptor antagonist casopitant mesylate for the prevention of cisplatin-induced nausea and vomiting

Roila, F. ; Rolski, J. ; Ramlau, R. ; Dediu, M. ; Russo, M. W. ; Bandekar, R. R. ; Grunberg, S. M.

Oxford: Oxford University Press

Texto completo disponível

Different effects of the BIM deletion polymorphism on treatment of solid tumors by the tyrosine kinase inhibitors (TKI) pazopanib, sunitinib, and lapatinib

Spraggs, C.F. ; Parham, L.R. ; Song, K. ; Briley, L.P. ; Johnson, T. ; Russo, M. ; Tada, H. ; du Bois, A. ; Xu, C.-F.

England: Elsevier Ltd

Texto completo disponível

The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings

Cavaletti, G. ; Cornblath, D.R. ; Merkies, I.S.J. ; Postma, T.J. ; Rossi, E. ; Frigeni, B. ; Alberti, P. ; Bruna, J. ; Velasco, R. ; Argyriou, A.A. ; Kalofonos, H.P. ; Psimaras, D. ; Ricard, D. ; Pace, A. ; Galiè, E. ; Briani, C. ; Dalla Torre, C. ; Faber, C.G. ; Lalisang, R.I. ; Boogerd, W. ; Brandsma, D. ; Koeppen, S. ; Hense, J. ; Storey, D. ; Kerrigan, S. ; Schenone, A. ; Fabbri, S. ; Valsecchi, M.G. ; Mazzeo, A. ; Pace, A. ; Pessino, A. ; Schenone, A. ; Toscano, A. ; Argyriou, A.A. ; Brouwer, B. ; Frigeni, B. ; Piras, B. ; Briani, C. ; Dalla Torre, C. ; Dominguez Gonzalez, C. ; Faber, C.G. ; Tomasello, C. ; Binda, D. ; Brandsma, D. ; Cortinovis, D. ; Psimaras, D. ; Ricard, D. ; Storey, D. ; Cornblath, D.R. ; Galiè, E. ; Lindeck Pozza, E. ; Rossi, E. ; Vanhoutte, E.K. ; Lanzani, F. ; Pastorelli, F. ; Altavilla, G. ; Cavaletti, G. ; Granata, G. ; Kalofonos, H.P. ; Ghignotti, I. ; Merkies, I.S.J. ; Bruna, J. ; Hense, J. ; Heimans, J.J. ; Mattavelli, L. ; Padua, L. ; Reni, L. ; Bakkers, M. ; Boogerd, M. ; Campagnolo, M. ; Cazzaniga, M. ; Eurelings, M. ; Leandri, M. ; Lucchetta, M. ; Penas Prado, M. ; Russo, M. ; Valsecchi, M.G. ; Piatti, M.L. ; Alberti, P. ; Bidoli, P. ; Grant, R. ; Plasmati, R. ; Velasco, R. ; Lalisang, R.I. ; Meijer, R.J. ; Fabbri, S. ; Dorsey, S.G. ; Galimberti, S. ; Kerrigan, S. ; Koeppen, S. ; Postma, T.J. ; Boogerd, W. ; Grisold, W.

Oxford: Elsevier Ltd

Texto completo disponível

361O Defining the prognostic role of MGMT methylation value by pyrosequencing assay in glioblastoma patients: A large Italian multicenter study

Caccese, M. ; Simonelli, M. ; Bellu, L. ; Villani, V. ; Rizzato, S. ; Ius, T. ; Pasqualetti, F. ; Russo, M. ; Franchino, F. ; Amoroso, R. ; Bertorelle, R. ; Cavallin, F. ; Dipasquale, A. ; Carosi, M. ; Pizzolitto, S. ; Cesselli, D. ; Gardiman, M.P. ; Padovan, M. ; Zagonel, V. ; Lombardi, G.

Elsevier Ltd

Texto completo disponível

CNS tumours The first study of dabrafenib in pediatric patients with BRAF V600–mutant relapsed or refractory low-grade gliomas

Kieran, M.W. ; Bouffet, E. ; Tabori, U. ; Broniscer, A. ; Cohen, K. ; Hansford, J. ; Geoerger, B. ; Hingorani, P. ; Dunkel, I. ; Russo, M. ; Tseng, L. ; Liu, Q. ; Nebot, N. ; Whitlock, J. ; Hargrave, D.

Elsevier Ltd

Texto completo disponível

Neoadjuvant Chemotherapy among Breast Cancer subtypes: a single-institution retrospective study

Ferrarini, I. ; Fontana, A. ; Bertolini, I. ; Diodati, L. ; De Angelis, C. ; Montagnani, I. ; Salvadori, B. ; Ghilli, M. ; Landucci, E. ; Lo Russo, M. ; Pfanner, E. ; Rossetti, E. ; Ferrari, P. ; Fustaino, L. ; Michelotti, A. ; Roncella, M. ; Falcone, A.

Texto completo disponível

Young women with metastatic breast cancer (mbc): a restrospective single institution analysis of clinical-pathological characteristics and outcomes

Fontana, A. ; Diodati, L. ; Bertolini, I. ; De Angelis, C. ; Ferrarini, I. ; Salvadori, B. ; Michelotti, A. ; Landucci, E. ; Pfanner, E. ; Ferrari, P. ; Lo Russo, M. ; Fustagno, L. ; Rossetti, E. ; Ghilli, M. ; Roncella, M. ; Falcone, A.

Texto completo disponível

Adjuvant endocrine therapy in elderly patient in early Breast Cancer, a less toxic therapy, is it really true? A single institution, “real life” experience

De Angelis, C. ; Bertolini, I. ; Ferrarini, I. ; Diodati, L. ; Montagnani, I. ; Fontana, A. ; Salvadori, B. ; Michelotti, A. ; Landucci, E. ; Paola, F. ; Pfanner, E. ; Lo Russo, M. ; Roncella, M. ; Falcone, A.

Texto completo disponível

Whole-exome sequencing of HER-2 positive human breast cancers: potential molecular mechanisms of response to neoadjuvant chemotherapy plus trastuzumab

La Ferla, M. ; Cantini, L. ; Aretini, P. ; Scatena, C. ; Bertolini, I. ; Fancelli, S. ; Ferrarini, I. ; De Angelis, C. ; Salvadori, B. ; Michelotti, A. ; Landucci, E. ; Ghilli, M. ; Fustaino, L. ; Lo Russo, M. ; Roncella, M. ; Falcone, A. ; Bevilacqua, G. ; Naccarato, G.A. ; Mazzanti, C.M. ; Fontana, A.

Texto completo disponível